miscsubjectsAI governance
Evidence review

BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair

· · 1 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-vs-nsaids-comparison`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-vs-nsaids-comparison

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-vs-nsaids-comparison/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What is the object in plain literal language?

BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.

Who claims what, from which source and evidence class?

User contrasts NSAIDs damaging gut lining with BPC-157 repairing it, highlighting protective/repairing benefits of BPC over NSAIDs.

Direct comparison: BPC-157 repairs NSAID gut damage (anecdotal, not advice).

X post (anecdotal experience shared): BPC-157 vs NSAID gut damage; user reports reduced bloating after 2 weeks oral 250-500mcg daily (anecdotal, not advice).

X post compares BPC-157 repair to NSAID damage; notes oral use for gut (anecdotal).

X post compares mechanisms: BPC-157 resolves vs NSAIDs suppress inflammation; focuses on gut repair from NSAID damage. No dosing anecdotes here.

X post recommends oral BPC-157 specifically for gut damage/NSAID inflammation; differentiates from injectable. Anecdotal context on use.

X post highlights BPC-157 restoring gut barrier amid NSAID use (positive repair anecdote/research).

X post lists BPC-157 reversing NSAID gut damage per study (anecdotal research summary).

Similar X post emphasizing BPC-157 reversal of NSAID gut damage.

X post summarizing BPC-157 benefits for NSAID gut damage (research-focused, not personal anecdote).

Reddit user discussion advising against concurrent NSAID use with BPC-157 due to its protective/reversing effects on GI damage.

Anecdotal advice on timing peptides separately from NSAIDs to avoid interference.

Anecdotal reports of combining BPC-157 with NSAIDs for pain without negative interactions, some noting additive effects.

User comment suggesting replacing ibuprofen (NSAID) with BPC-157 for sciatica recovery, implying better outcomes without NSAID side effects.

User reports positive healing for injuries/pain (potentially inflammatory) with BPC-157 stack, no negatives mentioned beyond cost; contrasts implicitly with ongoing NSAID use in community.

User discusses potential interactions between BPC-157 and ongoing NSAID use for chronic inflammation.

Anecdotal reports suggest BPC-157 may reduce NSAID-induced gut damage, but these claims lack rigorous scientific validation.

User reports successful gut repair from NSAID (aspirin) damage with oral BPC-157; benefits persisted after stopping if no new damage; mixed results from others on duration.

Positive but partial IBS-D improvement with BPC-157 that partially persisted off-cycle.

User with NSAID-induced gastritis reports significant symptom improvement and tolerance to triggers after oral + subq BPC-157; notes partial attribution to prior antibiotics.

Another user reports substantial reduction in gastritis/GERD symptoms after ~1 month of BPC-157.

User reports excellent results healing ulcers and gastritis with low-dose oral BPC-157, contrasting with NSAID damage; notes side effects at higher doses.

Bad outcome: severe adverse reaction (panic, vomiting, depression) while using BPC-157 for IBS-D, no significant IBS improvement.

Positive user experience: subQ BPC-157 resolved perceived IBS symptoms allowing normal eating, with some recurrence post-cycle.

Good outcome: BPC-157 rapidly healed NSAID (aspirin + steroids) induced stomach ulcers when prescribed by doctor.

Positive long-term oral BPC-157 experience for gut repair (bloating, post-meal pain), no side effects reported.

User noted rapid resolution of long-standing stomach ulcer symptoms after starting BPC-157 dosing.

A Reddit user discusses their experience or opinion regarding BPC-157 and NSAIDs.

A Reddit user discusses BPC-157, TB500, and anti-inflammatory drugs, potentially sharing personal experiences or observations.

Anecdotal research guide notes BPC-157 counteracts NSAID gut damage independently (anecdotal, not advice).

User seeking BPC-157 for gut repair possibly related to NSAID/GERD issues (anecdotal, not advice).

Discussion on BPC-157 for gut protection, implied vs NSAID damage (anecdotal, not advice).

Positive anecdotal outcome for gut healing; another notes 3-month course loved it (anecdotal, not advice).

Inquiry into BPC-157 for gut/IBS repair (anecdotal context, not advice).

Post summarizes research on BPC-157 protecting against NSAID ulcers and gut damage; notes oral effectiveness for GI (anecdotal context).

AMA discusses BPC-157 history and gut protection from NSAIDs; user comments reference healing effects (anecdotal).

Thread on BPC-157 for gut health and anti-inflammation; mentions NSAID context indirectly via healing (anecdotal dosing notes).

User reports stomach lining damage from long-term NSAID (ibuprofen) use and anecdotal positive experience with BPC-157 for recovery. Good outcome noted anecdotally, not advice.

Thread comparing peptides for gut issues including implied NSAID context; notes BPC-157's repair role. Anecdotal experiences may be in comments but not detailed here.

Anecdotal report of rapid gut improvement (better eating tolerance, mood) from BPC-157 use; other comments note resolved acid reflux/bloat, IBS relief, but some recurrence after stopping (anecdotal, not advice).

Anecdotal positive outcome: BPC-157 resolved long-term stomach issues including acid reflux and bloating during/after use for shoulder injury (anecdotal, not advice).

Anecdotal success story: sublingual/oral BPC-157 (500 mcg daily) eliminated IBS symptoms for over a month with no side effects (anecdotal, not advice).

Mixed anecdotal outcomes: positive for some with IBS, no improvement or negative responses reported by others (anecdotal, not advice).

Anecdotal/research summary on X: BPC-157 protects against NSAID-induced stomach damage and aids gut repair (anecdotal claims, not advice).

User reports switching from daily high-dose ibuprofen to peptides, implying gut/pain management benefits (anecdotal, not advice).

User anecdotal report of improved gut health while on BPC-157 (good outcome, labeled anecdotal).

Comment reports side effect of stomach pain and constipation from BPC-157 dosing (bad outcome, anecdotal).

Anecdotal post promoting oral BPC-157 (250-500 mcg daily, 4-6 weeks) for repairing GI lining and reducing gut inflammation; labels as general info not advice. No direct ibuprofen comparison but focuses on gut repair.

User comment notes ibuprofen stomach bleed risk and reports BPC-157 helped with pain (anecdotal, not advice).

Post highlights BPC-157 for healing/preventing NSAID-induced gastric damage (anecdotal context).

Promotes BPC-157 for NSAID gut repair based on studies; user mentions personal use but no specific bad outcomes or dosing anecdotes here.

Anecdotal reports summarized: gut healing in days, blocking ibuprofen damage. Labeled anecdotal, not advice. No specific side effects or dosing details.

Focuses on BPC-157 repairing NSAID-induced multi-organ damage including gut; personal testimonial implied but not detailed.

Anecdotal framing around rapid NSAID gut repair with BPC-157; emphasizes protection from ibuprofen damage.

Anecdotal discussion on using injectable BPC-157 for gut issues like IBS pain and bloating when oral causes reactions (possibly from fillers). Users report it works systemically; one notes lasting benefits after cycling with KPV, improved digestion. (Anecdotal, not advice).

Anecdotal report of complete gut repair (issues unspecified but resolved) with oral then subq BPC-157 + KPV; one cycle sufficient, worried about angiogenic effects due to family cancer history. (Anecdotal, not advice).

Thread highlights BPC-157 restoring tight junctions (claudin, occludin, ZO-1) in NSAID-induced leaky gut models, plus gut-brain axis benefits. Notes oral for gut targeting. (Research summary + anecdotal context).

X thread discusses how NSAIDs like ibuprofen damage gut (reducing natural BPC-157 repair signal), leading to stalled healing/scarring; promotes BPC-157 for actual repair including NSAID protection. Multiple replies in thread. (Anecdotal/research mix).

Anecdotal report of BPC-157 (in blend) helping IBS/GI issues potentially related to NSAID damage; user notes reduced urgency/anxiety around eating. Dosing: 250mcg daily (anecdotal, not advice). Positive GI outcome mentioned.

User attributes worsened GERD/GI issues to ibuprofen (NSAID), reports BPC-157 (oral, 2 caps AM/PM) helping healing lining/esophagus and reducing symptoms; positive outcome but notes need to continue other supports. Anecdotal.

Thread discusses potential interference of ibuprofen (NSAID) with BPC-157 healing; mixed anecdotal mentions of gut tolerance issues. Label as anecdotal, not advice.

X post mentions BPC-157 improving gut urgency/bloating (possibly NSAID-related context); positive anecdotal outcome for GI repair. Dosing not specified (anecdotal, not advice).

User anecdote: Started BPC-157 (anecdotal, not advice) to continue NSAID use; reported improved gut and major pain relief in hip injury. Labeled as personal experience only.

User reports stopping daily ibuprofen after starting BPC-157/TB500 stack (anecdotal); pain relief noted. Another user mentions similar stack success. Anecdotal only.

User tried ibuprofen unsuccessfully for tendinosis; planning oral BPC-157 (anecdotal dosing/experience, not advice).

User used higher dose BPC-157 for shoulder issue noting its gut healing origins (anecdotal, not advice).

What opened evidence establishes under the article's domain profile

2020 review detailing BPC-157's cytoprotective effects against NSAID-induced intestinal permeability issues and gastroenteropathy.

2013 review positioning BPC-157 as a potential NSAID antidote due to counteraction of GI, liver, brain lesions, bleeding, and other side effects.

Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.

2025 review citing BPC-157's cytoprotective effects against NSAID gut damage via permeability stabilization.

2024 review on BPC-157 for intestinal healing, referencing NSAID contexts in related work.

2017 study showing BPC-157 consistently antagonizes NSAID-induced sphincter pressure drops (diclofenac, ibuprofen, etc.).

2021 review discusses BPC-157's counteraction of NSAID toxicity alongside wound healing effects.

2025 review discussing BPC-157 NSAID rescue in gut contexts.

2022 review highlighting BPC-157 counteraction of NSAID GI lesions.

In rat studies BPC-157 reduced NSAID-induced GI lesions from indomethacin, aspirin, diclofenac

BPC 157 strongly antagonizes diclofenac-induced GI, liver, and brain toxicity in rats, acting as an antidote to NSAID side effects.

What is NOT known — explicit gaps

No human trials evaluate BPC-157 for NSAID-induced gut damage reversal

There is a lack of long-term studies on the effects of BPC-157 on NSAID-induced gut damage.

Discussion on combining BPC-157 with daily low-dose aspirin (NSAID); notes potential gut protective benefit against NSAID damage but cautions no human data, possible bleeding risk. Anecdotal suggestions to space doses (not advice).

Proposed mechanism (mechanistic tier only)

BPC-157 promotes angiogenesis and gut lining repair in animal models

NSAIDs inhibit COX enzymes to reduce pain and inflammation but can damage GI mucosa and impair healing

Limits of the evidence and exact unresolved questions

User discussion on potential interaction where NSAIDs like ibuprofen may counteract BPC-157 healing benefits.

Domain-specific safety statement when the subject requires one

Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.

Explore this article's relationships

NSAIDs · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedAOD 9604 for NsaidsARA 290 for NsaidsNsaidsBPC 157 for Nsaids
Evidence · 85 sources · swipe →chain 1ad07aaf3b35 · verify chain · provenance
1 / 85
Y
What Science ACTUALLY Says About BPC 157 Benefits
YouTube · Jun 29, 2026
2026-06-29 10:09s15 · #d57d39852af6
r/bpc_157· u/[deleted]
Did BPC 157 heal your digestive system and did the benefit benefits stay after you stopped taking it?
I originally took BPC-157 because taking a daily aspirin for a medical condition tore up my stomach. ... Within one month of taking it, I no longer had stomach symptoms. I stopped taking BPC-157, and the problems did not return. ... So, yes the healing lasts, but if there’s new damage I have to start over again to heal it.
⬆ • ⬇⤴ Share
2026-06-29 15:09s28 · #d8ffcc047556
r/CleanHealth· u/[deleted]
BPC-157 for Gut Health and Immunity
It enhances healing of the digestive tract by repairing the mucosal lining, reducing intestinal permeability (commonly known as “leaky gut”) and calming inflammation in the stomach and intestines. ... For gut specific issues the oral form is preferred since it works directly on the GI lining. ... Dosage and cycle length • 250 to 500 mcg daily • Oral capsule or subcutaneous injection near the abdominal area • Cycle: 4 to 6 weeks
⬆ • ⬇⤴ Share
2026-06-29 17:06s63 · #7afa7daf0282
r/bpc_157· u/[deleted]
Unexpected effect from the Wolverine blend
BPC-157 is gut-famous for a reason fixes NSAID damage, ulcers, leaky gut IBS relief tracks selank helps the anxiety piece, but the GI stability sounds like BPC doing its job same happened to me on BPC solo could eat sketchy airport food without paying for it later magic for anyone with food anxiety wolverine stack is overkill for just IBS, but since you're healing the ankle anyway, enjoy the bonus.
⬆ • ⬇⤴ Share
2026-06-29 17:08s76 · #2b328af42421
Evidence ledger 88 · tier-ranked · API
anecdotal
User discussion on potential interaction where NSAIDs like ibuprofen may counteract BPC-157 healing benefits.
sources: s13
human
No human trials evaluate BPC-157 for NSAID-induced gut damage reversal
sources: s4
human
2020 review detailing BPC-157's cytoprotective effects against NSAID-induced intestinal permeability issues and gastroenteropathy.
sources: s5
human
2013 review positioning BPC-157 as a potential NSAID antidote due to counteraction of GI, liver, brain lesions, bleeding, and other side effects.
sources: s6
human
Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence.
sources: s12, s15, s26, s4, s43
80 more ranked claims
human0.80
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.80
There is a lack of long-term studies on the effects of BPC-157 on NSAID-induced gut damage.
kimi/moonshot-v1-8k
This claim addresses the absence of long-term studies, which is a significant gap in the current understanding of BPC-157's effects on NSAID-induced gut damage.
sources: s4
human0.80
2025 review citing BPC-157's cytoprotective effects against NSAID gut damage via permeability stabilization.
grok/grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
human0.80
2024 review on BPC-157 for intestinal healing, referencing NSAID contexts in related work.
grok/grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
preclinical0.50
BPC-157 promotes angiogenesis and gut lining repair in animal models
system/repair
Core mapping to NSAID damage
sources: s1
preclinical0.50
2017 study showing BPC-157 consistently antagonizes NSAID-induced sphincter pressure drops (diclofenac, ibuprofen, etc.).
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
system0.35
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
mechanistic0.30
NSAIDs inhibit COX enzymes to reduce pain and inflammation but can damage GI mucosa and impair healing
system/repair
Establishes baseline problem framing
anecdotal0.30
User contrasts NSAIDs damaging gut lining with BPC-157 repairing it, highlighting protective/repairing benefits of BPC over NSAIDs.
grok/grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.30
Direct comparison: BPC-157 repairs NSAID gut damage (anecdotal, not advice).
grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
anecdotal0.30
X post (anecdotal experience shared): BPC-157 vs NSAID gut damage; user reports reduced bloating after 2 weeks oral 250-500mcg daily (anecdotal, not advice).
grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.30
X post compares BPC-157 repair to NSAID damage; notes oral use for gut (anecdotal).
grok-4.3
Materialized from orphan source s49 by ledger repair
sources: s49
anecdotal0.30
X post compares mechanisms: BPC-157 resolves vs NSAIDs suppress inflammation; focuses on gut repair from NSAID damage. No dosing anecdotes here.
grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
anecdotal0.30
X post recommends oral BPC-157 specifically for gut damage/NSAID inflammation; differentiates from injectable. Anecdotal context on use.
grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
anecdotal0.30
X post highlights BPC-157 restoring gut barrier amid NSAID use (positive repair anecdote/research).
grok-4.3
Materialized from orphan source s62 by ledger repair
sources: s62
anecdotal0.30
X post lists BPC-157 reversing NSAID gut damage per study (anecdotal research summary).
grok-4.3
Materialized from orphan source s66 by ledger repair
sources: s66
anecdotal0.30
Similar X post emphasizing BPC-157 reversal of NSAID gut damage.
grok-4.3
Materialized from orphan source s67 by ledger repair
sources: s67
anecdotal0.30
X post summarizing BPC-157 benefits for NSAID gut damage (research-focused, not personal anecdote).
grok-4.3
Materialized from orphan source s85 by ledger repair
sources: s85
human0.22low confidence
2021 review discusses BPC-157's counteraction of NSAID toxicity alongside wound healing effects.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
human0.22low confidence
2025 review discussing BPC-157 NSAID rescue in gut contexts.
grok/grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
human0.22low confidence
2022 review highlighting BPC-157 counteraction of NSAID GI lesions.
grok/grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
preclinical0.22low confidence
In rat studies BPC-157 reduced NSAID-induced GI lesions from indomethacin, aspirin, diclofenac
system/repair
Direct evidence separation from human data
sources: s2, s3
preclinical0.22low confidence
BPC 157 strongly antagonizes diclofenac-induced GI, liver, and brain toxicity in rats, acting as an antidote to NSAID side effects.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
Reddit user discussion advising against concurrent NSAID use with BPC-157 due to its protective/reversing effects on GI damage.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Anecdotal advice on timing peptides separately from NSAIDs to avoid interference.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
Anecdotal reports of combining BPC-157 with NSAIDs for pain without negative interactions, some noting additive effects.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
User comment suggesting replacing ibuprofen (NSAID) with BPC-157 for sciatica recovery, implying better outcomes without NSAID side effects.
grok/grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
User reports positive healing for injuries/pain (potentially inflammatory) with BPC-157 stack, no negatives mentioned beyond cost; contrasts implicitly with ongoing NSAID use in community.
grok/grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User discusses potential interactions between BPC-157 and ongoing NSAID use for chronic inflammation.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22low confidence
Anecdotal reports suggest BPC-157 may reduce NSAID-induced gut damage, but these claims lack rigorous scientific validation.
kimi/moonshot-v1-8k
This claim explicitly names anecdotal sources claiming BPC-157's protective effects against NSAID-induced gut damage, which were previously unattributed in the ledger.
sources: s8, s9
anecdotal0.22low confidence
User reports successful gut repair from NSAID (aspirin) damage with oral BPC-157; benefits persisted after stopping if no new damage; mixed results from others on duration.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
Positive but partial IBS-D improvement with BPC-157 that partially persisted off-cycle.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
User with NSAID-induced gastritis reports significant symptom improvement and tolerance to triggers after oral + subq BPC-157; notes partial attribution to prior antibiotics.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
Another user reports substantial reduction in gastritis/GERD symptoms after ~1 month of BPC-157.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User reports excellent results healing ulcers and gastritis with low-dose oral BPC-157, contrasting with NSAID damage; notes side effects at higher doses.
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.22low confidence
Bad outcome: severe adverse reaction (panic, vomiting, depression) while using BPC-157 for IBS-D, no significant IBS improvement.
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
Positive user experience: subQ BPC-157 resolved perceived IBS symptoms allowing normal eating, with some recurrence post-cycle.
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
Good outcome: BPC-157 rapidly healed NSAID (aspirin + steroids) induced stomach ulcers when prescribed by doctor.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
Positive long-term oral BPC-157 experience for gut repair (bloating, post-meal pain), no side effects reported.
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
User noted rapid resolution of long-standing stomach ulcer symptoms after starting BPC-157 dosing.
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
A Reddit user discusses their experience or opinion regarding BPC-157 and NSAIDs.
gemini-collaborator
Materializes an orphan anecdotal source, providing insight into user discussions.
sources: s8
anecdotal0.22low confidence
A Reddit user discusses BPC-157, TB500, and anti-inflammatory drugs, potentially sharing personal experiences or observations.
gemini-collaborator
Materializes another orphan anecdotal source, reflecting online community discussions.
sources: s9
anecdotal0.22low confidence
Anecdotal research guide notes BPC-157 counteracts NSAID gut damage independently (anecdotal, not advice).
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
anecdotal0.22low confidence
User seeking BPC-157 for gut repair possibly related to NSAID/GERD issues (anecdotal, not advice).
grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
anecdotal0.22low confidence
Discussion on BPC-157 for gut protection, implied vs NSAID damage (anecdotal, not advice).
grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
anecdotal0.22low confidence
Positive anecdotal outcome for gut healing; another notes 3-month course loved it (anecdotal, not advice).
grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
Inquiry into BPC-157 for gut/IBS repair (anecdotal context, not advice).
grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
Post summarizes research on BPC-157 protecting against NSAID ulcers and gut damage; notes oral effectiveness for GI (anecdotal context).
grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
anecdotal0.22low confidence
AMA discusses BPC-157 history and gut protection from NSAIDs; user comments reference healing effects (anecdotal).
grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Thread on BPC-157 for gut health and anti-inflammation; mentions NSAID context indirectly via healing (anecdotal dosing notes).
grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
anecdotal0.22low confidence
User reports stomach lining damage from long-term NSAID (ibuprofen) use and anecdotal positive experience with BPC-157 for recovery. Good outcome noted anecdotally, not advice.
grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
anecdotal0.22low confidence
Thread comparing peptides for gut issues including implied NSAID context; notes BPC-157's repair role. Anecdotal experiences may be in comments but not detailed here.
grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.22low confidence
Anecdotal report of rapid gut improvement (better eating tolerance, mood) from BPC-157 use; other comments note resolved acid reflux/bloat, IBS relief, but some recurrence after stopping (anecdotal, not advice).
grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Anecdotal positive outcome: BPC-157 resolved long-term stomach issues including acid reflux and bloating during/after use for shoulder injury (anecdotal, not advice).
grok-4.3
Materialized from orphan source s55 by ledger repair
sources: s55
anecdotal0.22low confidence
Anecdotal success story: sublingual/oral BPC-157 (500 mcg daily) eliminated IBS symptoms for over a month with no side effects (anecdotal, not advice).
grok-4.3
Materialized from orphan source s56 by ledger repair
sources: s56
anecdotal0.22low confidence
Mixed anecdotal outcomes: positive for some with IBS, no improvement or negative responses reported by others (anecdotal, not advice).
grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
anecdotal0.22low confidence
Anecdotal/research summary on X: BPC-157 protects against NSAID-induced stomach damage and aids gut repair (anecdotal claims, not advice).
grok-4.3
Materialized from orphan source s58 by ledger repair
sources: s58
anecdotal0.22low confidence
User reports switching from daily high-dose ibuprofen to peptides, implying gut/pain management benefits (anecdotal, not advice).
grok-4.3
Materialized from orphan source s59 by ledger repair
sources: s59
anecdotal0.22low confidence
User anecdotal report of improved gut health while on BPC-157 (good outcome, labeled anecdotal).
grok-4.3
Materialized from orphan source s60 by ledger repair
sources: s60
anecdotal0.22low confidence
Comment reports side effect of stomach pain and constipation from BPC-157 dosing (bad outcome, anecdotal).
grok-4.3
Materialized from orphan source s61 by ledger repair
sources: s61
anecdotal0.22low confidence
Anecdotal post promoting oral BPC-157 (250-500 mcg daily, 4-6 weeks) for repairing GI lining and reducing gut inflammation; labels as general info not advice. No direct ibuprofen comparison but focuses on gut repair.
grok-4.3
Materialized from orphan source s63 by ledger repair
sources: s63
anecdotal0.22low confidence
User comment notes ibuprofen stomach bleed risk and reports BPC-157 helped with pain (anecdotal, not advice).
grok-4.3
Materialized from orphan source s64 by ledger repair
sources: s64
anecdotal0.22low confidence
Post highlights BPC-157 for healing/preventing NSAID-induced gastric damage (anecdotal context).
grok-4.3
Materialized from orphan source s65 by ledger repair
sources: s65
anecdotal0.22low confidence
Promotes BPC-157 for NSAID gut repair based on studies; user mentions personal use but no specific bad outcomes or dosing anecdotes here.
grok-4.3
Materialized from orphan source s68 by ledger repair
sources: s68
anecdotal0.22low confidence
Anecdotal reports summarized: gut healing in days, blocking ibuprofen damage. Labeled anecdotal, not advice. No specific side effects or dosing details.
grok-4.3
Materialized from orphan source s69 by ledger repair
sources: s69
anecdotal0.22low confidence
Focuses on BPC-157 repairing NSAID-induced multi-organ damage including gut; personal testimonial implied but not detailed.
grok-4.3
Materialized from orphan source s70 by ledger repair
sources: s70
anecdotal0.22low confidence
Anecdotal framing around rapid NSAID gut repair with BPC-157; emphasizes protection from ibuprofen damage.
grok-4.3
Materialized from orphan source s71 by ledger repair
sources: s71
anecdotal0.22low confidence
Anecdotal discussion on using injectable BPC-157 for gut issues like IBS pain and bloating when oral causes reactions (possibly from fillers). Users report it works systemically; one notes lasting benefits after cycling with KPV, improved digestion. (Anecdotal, not advice).
grok-4.3
Materialized from orphan source s72 by ledger repair
sources: s72
anecdotal0.22low confidence
Anecdotal report of complete gut repair (issues unspecified but resolved) with oral then subq BPC-157 + KPV; one cycle sufficient, worried about angiogenic effects due to family cancer history. (Anecdotal, not advice).
grok-4.3
Materialized from orphan source s73 by ledger repair
sources: s73
anecdotal0.22low confidence
Thread highlights BPC-157 restoring tight junctions (claudin, occludin, ZO-1) in NSAID-induced leaky gut models, plus gut-brain axis benefits. Notes oral for gut targeting. (Research summary + anecdotal context).
grok-4.3
Materialized from orphan source s74 by ledger repair
sources: s74
anecdotal0.22low confidence
X thread discusses how NSAIDs like ibuprofen damage gut (reducing natural BPC-157 repair signal), leading to stalled healing/scarring; promotes BPC-157 for actual repair including NSAID protection. Multiple replies in thread. (Anecdotal/research mix).
grok-4.3
Materialized from orphan source s75 by ledger repair
sources: s75
anecdotal0.22low confidence
Anecdotal report of BPC-157 (in blend) helping IBS/GI issues potentially related to NSAID damage; user notes reduced urgency/anxiety around eating. Dosing: 250mcg daily (anecdotal, not advice). Positive GI outcome mentioned.
grok-4.3
Materialized from orphan source s76 by ledger repair
sources: s76
anecdotal0.22low confidence
Discussion on combining BPC-157 with daily low-dose aspirin (NSAID); notes potential gut protective benefit against NSAID damage but cautions no human data, possible bleeding risk. Anecdotal suggestions to space doses (not advice).
grok-4.3
Materialized from orphan source s77 by ledger repair
sources: s77
anecdotal0.22low confidence
User attributes worsened GERD/GI issues to ibuprofen (NSAID), reports BPC-157 (oral, 2 caps AM/PM) helping healing lining/esophagus and reducing symptoms; positive outcome but notes need to continue other supports. Anecdotal.
grok-4.3
Materialized from orphan source s78 by ledger repair
sources: s78
anecdotal0.22low confidence
Thread discusses potential interference of ibuprofen (NSAID) with BPC-157 healing; mixed anecdotal mentions of gut tolerance issues. Label as anecdotal, not advice.
grok-4.3
Materialized from orphan source s79 by ledger repair
sources: s79
anecdotal0.22low confidence
X post mentions BPC-157 improving gut urgency/bloating (possibly NSAID-related context); positive anecdotal outcome for GI repair. Dosing not specified (anecdotal, not advice).
grok-4.3
Materialized from orphan source s80 by ledger repair
sources: s80
anecdotal0.22low confidence
User anecdote: Started BPC-157 (anecdotal, not advice) to continue NSAID use; reported improved gut and major pain relief in hip injury. Labeled as personal experience only.
grok-4.3
Materialized from orphan source s81 by ledger repair
sources: s81
anecdotal0.22low confidence
User reports stopping daily ibuprofen after starting BPC-157/TB500 stack (anecdotal); pain relief noted. Another user mentions similar stack success. Anecdotal only.
grok-4.3
Materialized from orphan source s82 by ledger repair
sources: s82
anecdotal0.22low confidence
User tried ibuprofen unsuccessfully for tendinosis; planning oral BPC-157 (anecdotal dosing/experience, not advice).
grok-4.3
Materialized from orphan source s83 by ledger repair
sources: s83
anecdotal0.22low confidence
User used higher dose BPC-157 for shoulder issue noting its gut healing origins (anecdotal, not advice).
grok-4.3
Materialized from orphan source s84 by ledger repair
sources: s84
Low-confidence / auto-generated 3
speculative0.12
BPC 157 consistently antagonizes the sphincter pressure-lowering effects of various NSAIDs (diclofenac, ibuprofen, aspirin, etc.) in rat models.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
speculative0.12
2026 article details BPC-157 protecting against NSAID-induced gut damage via prostaglandin-independent pathways while preserving NSAID efficacy.
grok/grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
speculative0.12
2026 overview notes BPC-157 reverses NSAID GI damage, relevant for those using anti-inflammatories.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
Model review26 contributions · 6 modelsExpand the recursive review layer
1 / 26
grok/grok-4.3writer
redraft2026-06-29 08:42
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair · 4 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-vs-nsaids-evidence-review",
  "title": "BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair",
  "body": "## NSAIDs: Mechanism and Limitations\nNSAIDs inhibit COX enzymes to reduce prostaglandin-mediated pain and inflammation (mechanistic). This approach can damage gastrointestinal mucosa and impair tissue healing processes (preclinical).\n\n## BPC-157: Defined Mechanisms\nBPC-157 is a gastric juice-derived pentadecapeptide that promotes angiogenesis and local blood vessel formation into damaged tissue (mechanistic; preclinical). It supports gut lining repair in animal models (preclinical).\n\n## Rat Studies on NSAID-Induced Damage\nMultiple rat studies demonstrate BPC-157 reduces or reverses NSAID-induced gastrointestinal lesions. In one study, BPC-157 (10 μg/kg or 10 ng/kg i.p.) given with indomethacin, aspirin, or diclofenac consistently reduced stomach and small intestine lesions compared to controls (preclinical). Another study showed BPC-157 antagonized diclofenac-induced GI, liver, and brain lesions in rats when administered i.p. or orally (preclinical). Similar protective effects reported against celecoxib toxicity (preclinical).\n\nNo human trials have evaluated BPC-157 for reversal of NSAID-induced gut damage (no human data).\n\n## Tissue Repair Framing\nNSAIDs act via suppression of inflammatory pathways, which may slo
0aa4249ca631d221
grok-4.3source_hunt
sources2026-06-29 10:09
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
3 source(s) added
9423ba458f28a763
grok-4.3source_hunt
sources2026-06-29 10:09
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
3 source(s) added
3f48957755d73bae
grok-4.3source_hunt
sources2026-06-29 10:09
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
3 source(s) added
a670f10837519363
grok-4.3source_hunt
sources2026-06-29 10:10
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
4 source(s) added
102bf8ae008e7687
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
8e20cc8f873ac633
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
045fcf4b50e461e4
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
aa68a73efb5ea5dd
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
24042743016dbf04
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
{"materialized":0,"before":[],"after":[]}
229a1a4fba71c088
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:40
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
I am adding explicit gaps in knowledge and naming who claims what from anecdotes that are missing from the ledger. I am not Grok because I am focusing on filling the gaps and adding missing information, not challenging existing claims.
bb482cf2ce6e59a6
grok-4.3source_hunt
sources2026-06-29 13:51
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
46e9992ab5576da9
grok-4.3source_hunt
sources2026-06-29 15:09
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
6 source(s) added
c1585d6cb578aadc
grok-4.3source_hunt
sources2026-06-29 15:09
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
6 source(s) added
1f56c97e003683b0
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 16:31
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
As Gemini, not Grok, I focused on adding tier-honest claims using only provided source IDs and prioritizing 'what_is_unknown' and 'who_claims_what' slots. I added two anecdotal claims to materialize orphan Reddit sources and one preclinical claim highlighting a critical unknown regarding human safety, sourced from a review that also notes the absence of human trials. I did not challenge any claim as no suitable 'weak' claim with counter-evidence from the topology was identified.
970589c8ec9d0f41
grok-4.3source_hunt
sources2026-06-29 17:03
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
562a2786d1482044
grok-4.3source_hunt
sources2026-06-29 17:03
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
d7d699e26f2e2137
grok-4.3source_hunt
sources2026-06-29 17:04
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
4 source(s) added
505256fd6fb22401
grok-4.3source_hunt
sources2026-06-29 17:05
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
c2d2d1bc2c1ac0ea
grok-4.3source_hunt
sources2026-06-29 17:06
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
93d282a1ea482acb
grok-4.3source_hunt
sources2026-06-29 17:06
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
97a2152b3f79b85f
grok-4.3source_hunt
sources2026-06-29 17:07
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
4 source(s) added
74406355a9981435
grok-4.3source_hunt
sources2026-06-29 17:08
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
b9b704b4133c6ec5
grok-4.3source_hunt
sources2026-06-29 17:08
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
e8139626b0a95be6
grok-4.3source_hunt
sources2026-06-29 17:23
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison
it output
5 source(s) added
dea5d83855e48241
fill-slotsclaim_post
claim2026-06-29 20:22
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-nsaids-comparison c96
it output
BPC-157 Compared to NSAIDs: Preclinical Data on Gut Protection and Tissue Repair is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
04f15f27d9665e73
Machine verification: /api/articles/bpc-vs-nsaids-comparison/contributions

Related articles

NSAIDs · drug map

Open evidence map →
BPC-157: Body Protection Compoundembedded in this articlebpc-157AOD 9604 for Nsaidscrosses NSAIDsaod-9604-nsaidsARA 290 for Nsaidscrosses NSAIDsara-290-nsaidsNsaidscrosses NSAIDsbdnf-explained-nsaidsBPC 157 for Nsaidscrosses NSAIDsbpc-157-nsaidsNsaidscrosses NSAIDscjc-1295-nsaids
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (anecdotal tier): "User discussion on potential interaction where NSAIDs like ibuprofen may counteract BPC-157 healing benefits."?
ask bpc-vs-nsaids-comparison claim c13 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials evaluate BPC-157 for NSAID-induced gut damage reversal"?
ask bpc-vs-nsaids-comparison claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "2020 review detailing BPC-157's cytoprotective effects against NSAID-induced intestinal permeability issues and gastroenteropathy."?
ask bpc-vs-nsaids-comparison claim c5 · paste includes §SELF
What does the ledger say about this (human tier): "2013 review positioning BPC-157 as a potential NSAID antidote due to counteraction of GI, liver, brain lesions, bleeding, and other side eff…"?
ask bpc-vs-nsaids-comparison claim c6 · paste includes §SELF
What does the ledger say about this (human tier): "Commercial vendors and clinics market this compound (5 commercial/clinic sources catalogued) — marketing material, not evidence."?
ask bpc-vs-nsaids-comparison claim c12 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-vs-nsaids-comparison claim c27 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit user discussion advising against concurrent NSAID use with BPC-157 due to its protective/reversing effects on GI "
ask bpc-vs-nsaids-comparison source s8 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Anecdotal advice on timing peptides separately from NSAIDs to avoid interference."
ask bpc-vs-nsaids-comparison source s9 · paste includes §SELF
bpc-vs-nsaids-comparison · posted 2026-06-29 · updated 2026-07-17 · 35 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 36 model passes · 6879 tokens · $0 · 8 models
chain head af130381e4ecd56b
write grok/grok-4.3 · 2026-06-29 08:42 · 0 tok · 1d5ab3859377
sources grok-4.3 · 2026-06-29 10:09 · 0 tok · 438d9f80c5b2
sources grok-4.3 · 2026-06-29 10:09 · 0 tok · daffed2d2455
sources grok-4.3 · 2026-06-29 10:09 · 0 tok · 250d6747c8f8
sources grok-4.3 · 2026-06-29 10:10 · 0 tok · 49ec3d45a4c7
repair repair · 2026-06-29 12:29 · 0 tok · b2ab5c37a022
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · f42bcc4c607d
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 3b6609cb451c
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · fa90606e691c
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 5f554b516044
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 417451f0aaf2
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · f2f17164800b
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · 3a814d324c75
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · 07d42f16daae
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · 7ac02d279a23
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:40 · 3525 tok · aad38899e4c5
sources grok-4.3 · 2026-06-29 13:51 · 0 tok · 708dccb79113
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · de3b60214314
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · f0f7bf23250d
sources grok-4.3 · 2026-06-29 15:09 · 0 tok · 96097b38e33b
sources grok-4.3 · 2026-06-29 15:09 · 0 tok · f78121943b45
collaborate gemini/gemini-2.5-flash · 2026-06-29 16:31 · 3354 tok · 2d43581ea080
sources grok-4.3 · 2026-06-29 17:03 · 0 tok · c3f2c7d2ebfa
sources grok-4.3 · 2026-06-29 17:03 · 0 tok · 7d163a54c6c1
sources grok-4.3 · 2026-06-29 17:04 · 0 tok · 268542d4a36d
sources grok-4.3 · 2026-06-29 17:05 · 0 tok · 0d1ebf7e0a4b
sources grok-4.3 · 2026-06-29 17:06 · 0 tok · 41795137bbd6
sources grok-4.3 · 2026-06-29 17:06 · 0 tok · c7c03e7b6d6a
sources grok-4.3 · 2026-06-29 17:07 · 0 tok · 3808f2401d1e
sources grok-4.3 · 2026-06-29 17:08 · 0 tok · b97753bf4132
sources grok-4.3 · 2026-06-29 17:08 · 0 tok · 863e3efb963b
sources grok-4.3 · 2026-06-29 17:23 · 0 tok · c206276ec0cc
repair repair · 2026-06-29 19:08 · 0 tok · e8768e6ce850
repair repair · 2026-06-29 19:17 · 0 tok · a1b62db494be
claim fill-slots · 2026-06-29 20:22 · 0 tok · 57ee89c5fe43
voxel_divide owner · 2026-07-17 02:38 · 0 tok · af130381e4ec
verify chain →
Live ledger · 47 payloads · 0 turns
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 16:20
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 16:12
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 15:33
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 13:41
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 13:41
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 13:28
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-vs-nsaids-comparison · GET /api/articles/bpc-vs-nsaids-comparison?format=post (the editable body)
create/replace POST /api/articles/bpc-vs-nsaids-comparison · PUT /api/articles/bpc-vs-nsaids-comparison (replace, keeps revision) · PATCH /api/articles/bpc-vs-nsaids-comparison (merge)
delete DELETE /api/articles/bpc-vs-nsaids-comparison
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-vs-nsaids-comparison/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-vs-nsaids-comparison/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-vs-nsaids-comparison|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…